(S)-2-(2-((tert-Butoxycarbonyl)amino)-3-(1-trityl-1H-imidazol-4-yl)propanamido)-2-methylpropanoic acid

Catalog No. :
ACHIMY048
CAS No. :
2061897-68-3
Molecular Formula :
C34H38N4O5
Molecular Weight :
582.70

IUPAC Name:(S)-2-(2-((tert-butoxycarbonyl)amino)-3-(1-trityl-1H-imidazol-4-yl)propanamido)-2-methylpropanoic acid

(S)-2-(2-((tert-Butoxycarbonyl)amino)-3-(1-trityl-1H-imidazol-4-yl)propanamido)-2-methylpropanoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$74.00Login to see priceIn stockIn stock
25g98%$222.00Login to see priceIn stockIn stock
100g98%$754.00Login to see priceIn stockInquiry
500g98%$2986.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-2-(2-((tert-Butoxycarbonyl)amino)-3-(1-trityl-1H-imidazol-4-yl)propanamido)-2-methylpropanoic acid
IUPAC Name(S)-2-(2-((tert-butoxycarbonyl)amino)-3-(1-trityl-1H-imidazol-4-yl)propanamido)-2-methylpropanoic acid
MDL No.MFCD32173661
Molecular FormulaC34H38N4O5
Molecular Weight582.70
SMILESCC(C)(NC([C@@H](NC(OC(C)(C)C)=O)CC1=CN(C(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4)C=N1)=O)C(O)=O
InChI KeyPOZCMPSLNOUKQN-NDEPHWFRSA-N
SynonymBoc-His(Trt)-Aib-OH
CAS No.2061897-68-3
PubChem CID124179955

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACHIMY048 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHIMY048 route product structure diagram
    ACHIMY0482061897-68-3 In Stock
Inquiry

2. ACHIMY048 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHIMY048 route product structure diagram
    ACHIMY0482061897-68-3 In Stock
Inquiry

Comments (0)